Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJE6W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $54,240
Award facts
- Contract value 100% obligated
- $54,239.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $54,239.64 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on December 19, 2025, with an ultimate completion date of December 22, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Dupixent is a specialty immunosuppressant medication used to treat various inflammatory conditions, reflecting the critical role AmerisourceBergen plays in supplying specialized pharmaceuticals to military and federal healthcare systems.
AmerisourceBergen Drug Corp has established itself as a primary vendor for the Defense Logistics Agency's medical supply chain, consistently winning competitive awards across therapeutic domains including diabetes medications, neurological treatments, and specialty injectable medications. The company's substantial indefinite delivery vehicle enables flexible procurement of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers globally. This delivery order exemplifies the routine pharmaceutical fulfillment operations under the broader prime vendor contract, supporting the military healthcare infrastructure's ongoing medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FJE6W?
SPE2DR26FJE6W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FJE6W worth?
The government has obligated $54,240 on SPE2DR26FJE6W.
Is contract SPE2DR26FJE6W an order under another contract?
Yes. SPE2DR26FJE6W is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJE6W competed?
The extent of competition for SPE2DR26FJE6W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award